莱斯康制药 | 1.13 -0.06 -5.04% | ||
| LXRX | |||
| 高 1.20 | 开 1.19 | 量 125.58万股 | 总市值 4.11亿 |
| 低 1.13 | 换 0.35% | 额 145.53万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
莱斯康制药(LXRX)
08-07 04:45
$莱斯康制药(LXRX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001628280-25-038387 Act: 33 Size: 224 KB 网页链接
1赞
莱斯康制药(LXRX)
07-03 21:15
$莱斯康制药(LXRX)$ 8-K Current report, item 8.01 Accession Number: 0001062822-25-000035 Act: 34 Size: 136 KB 网页链接
莱斯康制药(LXRX)
06-04 04:15
$莱斯康制药(LXRX)$ 8-K Current report, items 1.01, 5.07, and 9.01 Accession Number: 0001062822-25-000033 Act: 34 Size: 7 MB 网页链接
莱斯康制药(LXRX)
06-04 04:25
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016473 Size: 7 KB 网页链接
莱斯康制药(LXRX)
07-28 19:45
$莱斯康制药(LXRX)$ 8-K Current report, item 8.01 Accession Number: 0001062822-25-000037 Act: 34 Size: 135 KB 网页链接
莱斯康制药(LXRX)
06-07 05:45
$莱斯康制药(LXRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001127602-25-017010 Size: 7 KB 网页链接
莱斯康制药(LXRX)
06-04 04:25
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016465 Size: 7 KB 网页链接
莱斯康制药(LXRX)
06-04 04:25
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016476 Size: 7 KB 网页链接
莱斯康制药(LXRX)
07-08 21:15
$莱斯康制药(LXRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-001680 Act: 34 Size: 11 KB 网页链接
莱斯康制药(LXRX)
08-07 04:25
$莱斯康制药(LXRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-038340 Act: 34 Size: 5 MB 网页链接
山月长明
08-16 07:14
$莱斯康制药(LXRX)$
发现一直小而美观察标的
发现一直小而美观察标的
莱斯康制药(LXRX)
06-04 04:25
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016458 Size: 7 KB 网页链接
莱斯康制药(LXRX)
06-04 04:25
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016461 Size: 7 KB 网页链接
莱斯康制药(LXRX)
06-04 04:35
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016480 Size: 7 KB 网页链接
莱斯康制药(LXRX)
08-06 19:35
$莱斯康制药(LXRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001062822-25-000042 Act: 34 Size: 232 KB 网页链接
莱斯康制药(LXRX)
06-04 04:25
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-016471 Size: 7 KB 网页链接
莱斯康制药(LXRX)
06-09 22:05
$莱斯康制药(LXRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001127602-25-017051 Size: 17 KB 网页链接